InBodyLtd Past Earnings Performance
Past criteria checks 3/6
InBodyLtd has been growing earnings at an average annual rate of 15.7%, while the Medical Equipment industry saw earnings growing at 11.2% annually. Revenues have been growing at an average rate of 11.4% per year. InBodyLtd's return on equity is 14.6%, and it has net margins of 21.6%.
Key information
15.7%
Earnings growth rate
16.4%
EPS growth rate
| Medical Equipment Industry Growth | 22.7% |
| Revenue growth rate | 11.4% |
| Return on equity | 14.6% |
| Net Margin | 21.6% |
| Last Earnings Update | 31 Dec 2023 |
Recent past performance updates
Recent updates
InBodyLtd (KOSDAQ:041830) Could Be Struggling To Allocate Capital
Apr 12
Why Dividend Hunters Love InBody Co.,Ltd (KOSDAQ:041830)
Mar 25Can InBody Co.,Ltd (KOSDAQ:041830) Performance Keep Up Given Its Mixed Bag Of Fundamentals?
Mar 08Do Insiders Own Lots Of Shares In InBody Co.,Ltd (KOSDAQ:041830)?
Feb 18
How Much Did InBodyLtd's(KOSDAQ:041830) Shareholders Earn From Share Price Movements Over The Last Five Years?
Jan 31Has InBodyLtd (KOSDAQ:041830) Got What It Takes To Become A Multi-Bagger?
Jan 11InBody Co., Ltd. (KOSDAQ:041830) Looks Like A Good Stock, And It's Going Ex-Dividend Soon
Dec 24Why Dividend Hunters Love InBody Co., Ltd. (KOSDAQ:041830)
Dec 17InBody Co., Ltd.'s (KOSDAQ:041830) Stock is Soaring But Financials Seem Inconsistent: Will The Uptrend Continue?
Dec 02Do Institutions Own InBody Co., Ltd. (KOSDAQ:041830) Shares?
Nov 17Revenue & Expenses BreakdownBeta
How InBodyLtd makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 31 Dec 23 | 170,351 | 36,723 | 78,054 | 9,311 |
| 30 Sep 23 | 171,523 | 35,376 | 75,130 | 9,341 |
| 30 Jun 23 | 165,663 | 32,528 | 72,999 | 9,176 |
| 31 Mar 23 | 164,431 | 34,112 | 69,872 | 9,212 |
| 31 Dec 22 | 160,004 | 33,816 | 66,233 | 8,779 |
| 30 Sep 22 | 154,925 | 36,465 | 62,390 | 8,719 |
| 30 Jun 22 | 149,075 | 34,329 | 58,291 | 8,834 |
| 31 Mar 22 | 143,399 | 34,038 | 55,390 | 8,523 |
| 31 Dec 21 | 137,837 | 34,033 | 52,427 | 8,062 |
| 30 Sep 21 | 128,762 | 31,729 | 50,364 | 6,968 |
| 30 Jun 21 | 125,036 | 30,556 | 49,625 | 6,382 |
| 31 Mar 21 | 112,334 | 22,620 | 47,372 | 5,529 |
| 31 Dec 20 | 107,122 | 17,518 | 47,566 | 5,801 |
| 30 Sep 20 | 109,493 | 14,492 | 49,203 | 6,024 |
| 30 Jun 20 | 107,806 | 13,559 | 48,998 | 5,535 |
| 31 Mar 20 | 116,393 | 19,969 | 49,358 | 5,947 |
| 31 Dec 19 | 117,059 | 20,428 | 48,725 | 5,243 |
| 30 Sep 19 | 113,404 | 21,164 | 45,117 | 5,324 |
| 30 Jun 19 | 110,791 | 22,187 | 43,529 | 5,249 |
| 31 Mar 19 | 106,381 | 21,398 | 42,711 | 5,300 |
| 31 Dec 18 | 99,635 | 19,671 | 41,344 | 5,211 |
| 30 Sep 18 | 98,925 | 21,918 | 39,891 | 5,395 |
| 30 Jun 18 | 98,352 | 21,686 | 38,516 | 5,803 |
| 31 Mar 18 | 95,337 | 20,570 | 36,852 | 6,293 |
| 31 Dec 17 | 93,254 | 19,322 | 34,886 | 7,250 |
| 30 Sep 17 | 86,462 | 17,506 | 33,432 | 6,714 |
| 30 Jun 17 | 80,006 | 14,859 | 31,588 | 6,463 |
| 31 Mar 17 | 76,806 | 14,574 | 29,829 | 5,966 |
| 31 Dec 16 | 79,848 | 16,987 | 28,382 | 5,377 |
| 30 Sep 16 | 79,954 | 16,853 | 26,572 | 5,400 |
| 30 Jun 16 | 80,356 | 19,165 | 25,136 | 5,382 |
| 31 Mar 16 | 76,561 | 18,359 | 23,636 | 5,011 |
| 31 Dec 15 | 68,949 | 17,311 | 22,847 | 4,882 |
| 30 Sep 15 | 61,594 | 13,802 | 18,959 | 7,035 |
| 30 Jun 15 | 54,675 | 10,615 | 18,408 | 5,887 |
| 31 Mar 15 | 52,053 | 9,302 | 20,827 | 3,923 |
| 31 Dec 14 | 48,940 | 8,879 | 19,683 | 3,392 |
| 30 Sep 14 | 45,498 | 9,160 | 18,739 | 2,711 |
| 30 Jun 14 | 42,966 | 8,362 | 18,266 | 2,540 |
| 31 Mar 14 | 39,831 | 7,060 | 16,612 | 2,758 |
| 31 Dec 13 | 36,787 | 6,194 | 15,918 | 2,711 |
| 30 Sep 13 | 35,676 | 5,545 | 16,544 | 2,289 |
| 30 Jun 13 | 34,602 | 5,357 | 16,471 | 2,289 |
Quality Earnings: A041830 has high quality earnings.
Growing Profit Margin: A041830's current net profit margins (21.6%) are higher than last year (21.1%).
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: A041830's earnings have grown by 15.7% per year over the past 5 years.
Accelerating Growth: A041830's earnings growth over the past year (8.6%) is below its 5-year average (15.7% per year).
Earnings vs Industry: A041830 earnings growth over the past year (8.6%) did not outperform the Medical Equipment industry 8.8%.
Return on Equity
High ROE: A041830's Return on Equity (14.6%) is considered low.